Share Price and Basic Stock Data
Last Updated: January 3, 2026, 10:50 am
| PEG Ratio | 0.80 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Akzo Nobel India Ltd operates within the paints and varnishes sector, a market characterized by robust demand driven by urbanization and infrastructure development. The company’s stock price stood at ₹3,212 with a market capitalization of ₹14,626 Cr. Revenue from operations reported a steady increase, rising from ₹3,149 Cr in March 2022 to ₹3,802 Cr in March 2023, and further projected at ₹4,091 Cr for March 2025. Quarterly sales figures reflected this upward trend, with sales reaching ₹1,033 Cr in December 2023 and expected to maintain momentum into subsequent quarters. The company reported a trailing twelve-month (TTM) revenue of ₹3,903 Cr, indicating a healthy growth trajectory. The operating profit margin (OPM) settled at 16% for the fiscal year ending March 2025, consistent with the previous year’s performance, showcasing operational efficiency in managing costs against revenue growth.
Profitability and Efficiency Metrics
Profitability metrics for Akzo Nobel India Ltd remain robust, with a reported net profit of ₹1,990 Cr for the fiscal year ending March 2025, translating to an impressive return on equity (ROE) of 32.2%. The interest coverage ratio (ICR) stood at 68.28x, significantly higher than typical sector averages, indicating strong earnings relative to interest obligations. The company maintained a net profit margin of 10.49% for March 2025, showcasing effective cost control and pricing strategies. Operating profit for March 2025 was recorded at ₹642 Cr, with an operating profit margin of 16%, reflecting consistent operational efficiency. The company’s cash conversion cycle (CCC) was reported at -3 days, indicating efficient management of working capital, thus enhancing liquidity and operational performance.
Balance Sheet Strength and Financial Ratios
The balance sheet of Akzo Nobel India Ltd indicates solid financial health, with total assets reported at ₹2,902 Cr for March 2025, against borrowings of ₹71 Cr. This low level of debt positions the company favorably in terms of financial stability. The company’s reserves rose significantly to ₹2,208 Cr as of September 2025, demonstrating its capacity to reinvest earnings and support future growth initiatives. The price-to-book value (P/BV) ratio stood at 12.32x, which is relatively high but reflects investor confidence in the company’s growth potential. The return on capital employed (ROCE) was reported at 41.7%, showcasing effective utilization of capital to generate profits. Furthermore, the company’s current ratio of 1.38x indicates a strong liquidity position, suggesting it can comfortably meet its short-term liabilities.
Shareholding Pattern and Investor Confidence
Akzo Nobel India Ltd’s shareholding pattern reveals a strong promoter holding of 69.76%, which is a positive indicator of management’s confidence in the company’s long-term prospects. Foreign institutional investors (FIIs) increased their stake to 7.97% as of September 2025, up from 2.71% in December 2022, indicating growing confidence from international markets. Domestic institutional investors (DIIs) also increased their holdings to 13.77%, reflecting a favorable outlook among local investors. The total number of shareholders stood at 48,226, suggesting a broad base of retail and institutional investors. However, the decline in promoter holding from 74.76% in December 2022 could raise concerns about potential dilution of control, although the overall increase in institutional holdings may counterbalance this risk.
Outlook, Risks, and Final Insight
Looking ahead, Akzo Nobel India Ltd is well-positioned to capitalize on the growing demand within the paints and coatings sector, particularly as infrastructure projects gain momentum. However, the company faces risks including potential volatility in raw material prices and economic slowdowns that could impact consumer spending. Additionally, competition within the sector remains fierce, which could pressure margins. Nevertheless, the company’s strong profitability metrics, low leverage, and efficient operations present significant strengths. Should the company successfully navigate these challenges while maintaining operational efficiency, it could continue to deliver value to its shareholders. Conversely, if economic conditions worsen or competitive pressures intensify, the company may experience challenges in sustaining its growth trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Sirca Paints India Ltd | 2,860 Cr. | 504 | 539/231 | 49.4 | 78.0 | 0.30 % | 20.0 % | 14.9 % | 10.0 |
| Shalimar Paints Ltd | 631 Cr. | 75.4 | 144/54.1 | 34.0 | 0.00 % | 12.8 % | 22.6 % | 2.00 | |
| Kansai Nerolac Paints Ltd | 19,492 Cr. | 241 | 275/218 | 29.9 | 80.1 | 1.04 % | 13.0 % | 10.4 % | 1.00 |
| Berger Paints India Ltd | 61,106 Cr. | 524 | 605/443 | 55.3 | 53.9 | 0.73 % | 24.9 % | 20.3 % | 1.00 |
| Akzo Nobel India Ltd | 14,626 Cr. | 3,212 | 3,958/3,022 | 37.5 | 495 | 3.11 % | 41.7 % | 32.2 % | 10.0 |
| Industry Average | 60,777.00 Cr | 1,221.57 | 47.66 | 157.50 | 1.01% | 23.02% | 20.17% | 4.17 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 926 | 987 | 951 | 999 | 956 | 1,033 | 973 | 1,036 | 982 | 1,050 | 1,022 | 995 | 835 |
| Expenses | 820 | 844 | 797 | 837 | 814 | 866 | 812 | 867 | 836 | 884 | 863 | 861 | 724 |
| Operating Profit | 106 | 143 | 155 | 162 | 142 | 166 | 162 | 169 | 146 | 167 | 159 | 134 | 111 |
| OPM % | 11% | 14% | 16% | 16% | 15% | 16% | 17% | 16% | 15% | 16% | 16% | 14% | 13% |
| Other Income | 5 | 12 | 6 | 8 | 9 | 8 | 10 | 10 | 9 | 6 | 3 | 9 | 1,882 |
| Interest | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 3 | 2 |
| Depreciation | 20 | 21 | 22 | 19 | 21 | 20 | 22 | 22 | 22 | 23 | 22 | 18 | 18 |
| Profit before tax | 88 | 132 | 133 | 148 | 127 | 152 | 147 | 154 | 132 | 146 | 137 | 122 | 1,972 |
| Tax % | 26% | 26% | 28% | 26% | 26% | 25% | 26% | 26% | 26% | 26% | 22% | 26% | 15% |
| Net Profit | 65 | 97 | 95 | 110 | 94 | 114 | 109 | 115 | 98 | 109 | 108 | 91 | 1,683 |
| EPS in Rs | 14.36 | 21.39 | 20.95 | 24.13 | 20.68 | 24.99 | 23.89 | 25.16 | 21.50 | 23.85 | 23.61 | 19.98 | 369.50 |
Last Updated: January 2, 2026, 2:03 pm
Below is a detailed analysis of the quarterly data for Akzo Nobel India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 835.00 Cr.. The value appears to be declining and may need further review. It has decreased from 995.00 Cr. (Jun 2025) to 835.00 Cr., marking a decrease of 160.00 Cr..
- For Expenses, as of Sep 2025, the value is 724.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 861.00 Cr. (Jun 2025) to 724.00 Cr., marking a decrease of 137.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 111.00 Cr.. The value appears to be declining and may need further review. It has decreased from 134.00 Cr. (Jun 2025) to 111.00 Cr., marking a decrease of 23.00 Cr..
- For OPM %, as of Sep 2025, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 14.00% (Jun 2025) to 13.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 1,882.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Jun 2025) to 1,882.00 Cr., marking an increase of 1,873.00 Cr..
- For Interest, as of Sep 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Jun 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 18.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 1,972.00 Cr.. The value appears strong and on an upward trend. It has increased from 122.00 Cr. (Jun 2025) to 1,972.00 Cr., marking an increase of 1,850.00 Cr..
- For Tax %, as of Sep 2025, the value is 15.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Jun 2025) to 15.00%, marking a decrease of 11.00%.
- For Net Profit, as of Sep 2025, the value is 1,683.00 Cr.. The value appears strong and on an upward trend. It has increased from 91.00 Cr. (Jun 2025) to 1,683.00 Cr., marking an increase of 1,592.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 369.50. The value appears strong and on an upward trend. It has increased from 19.98 (Jun 2025) to 369.50, marking an increase of 349.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:41 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,332 | 2,442 | 2,640 | 2,572 | 2,719 | 2,918 | 2,662 | 2,421 | 3,149 | 3,802 | 3,962 | 4,091 | 3,903 |
| Expenses | 2,141 | 2,181 | 2,380 | 2,244 | 2,420 | 2,576 | 2,291 | 2,078 | 2,714 | 3,276 | 3,328 | 3,449 | 3,332 |
| Operating Profit | 192 | 261 | 260 | 329 | 300 | 342 | 370 | 343 | 434 | 526 | 633 | 642 | 571 |
| OPM % | 8% | 11% | 10% | 13% | 11% | 12% | 14% | 14% | 14% | 14% | 16% | 16% | 15% |
| Other Income | 57 | 68 | 110 | 65 | 240 | 43 | 41 | 21 | 23 | 26 | 35 | 27 | 1,900 |
| Interest | 2 | 2 | 2 | 3 | 4 | 4 | 9 | 10 | 14 | 14 | 12 | 10 | 11 |
| Depreciation | 44 | 53 | 54 | 54 | 58 | 65 | 79 | 76 | 76 | 82 | 82 | 89 | 82 |
| Profit before tax | 203 | 275 | 314 | 337 | 478 | 316 | 323 | 278 | 367 | 456 | 573 | 570 | 2,378 |
| Tax % | 26% | 32% | 32% | 27% | 16% | 33% | 27% | 25% | 21% | 26% | 26% | 25% | |
| Net Profit | 150 | 186 | 214 | 247 | 401 | 211 | 237 | 208 | 290 | 335 | 427 | 429 | 1,990 |
| EPS in Rs | 32.19 | 39.93 | 45.91 | 52.94 | 85.85 | 46.33 | 52.13 | 45.59 | 63.68 | 73.58 | 93.70 | 94.11 | 436.94 |
| Dividend Payout % | 233% | 50% | 153% | 42% | 26% | 52% | 27% | 110% | 118% | 88% | 80% | 106% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 24.00% | 15.05% | 15.42% | 62.35% | -47.38% | 12.32% | -12.24% | 39.42% | 15.52% | 27.46% | 0.47% |
| Change in YoY Net Profit Growth (%) | 0.00% | -8.95% | 0.37% | 46.93% | -109.73% | 59.70% | -24.56% | 51.66% | -23.91% | 11.95% | -26.99% |
Akzo Nobel India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 9% |
| 3 Years: | 9% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 21% |
| 1 Year: | -4% |
| Return on Equity | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 26% |
| 3 Years: | 30% |
| Last Year: | 32% |
Last Updated: September 4, 2025, 10:40 pm
Balance Sheet
Last Updated: December 4, 2025, 12:55 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 47 | 47 | 47 | 47 | 47 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 |
| Reserves | 801 | 873 | 1,116 | 962 | 1,244 | 1,090 | 1,192 | 1,242 | 1,213 | 1,270 | 1,284 | 1,283 | 2,208 |
| Borrowings | 0 | 0 | 3 | 3 | 3 | 3 | 64 | 64 | 70 | 70 | 60 | 62 | 71 |
| Other Liabilities | 1,191 | 879 | 878 | 872 | 938 | 959 | 1,024 | 1,178 | 1,261 | 1,354 | 1,513 | 1,511 | 1,315 |
| Total Liabilities | 2,039 | 1,799 | 2,043 | 1,884 | 2,231 | 2,097 | 2,325 | 2,529 | 2,590 | 2,739 | 2,903 | 2,902 | 3,640 |
| Fixed Assets | 502 | 516 | 523 | 519 | 539 | 530 | 574 | 543 | 520 | 511 | 526 | 481 | 1,580 |
| CWIP | 31 | 12 | 9 | 23 | 27 | 17 | 16 | 16 | 42 | 73 | 119 | 67 | 74 |
| Investments | 629 | 394 | 600 | 336 | 573 | 377 | 84 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 877 | 876 | 911 | 1,006 | 1,092 | 1,173 | 1,652 | 1,969 | 2,029 | 2,156 | 2,258 | 2,354 | 1,987 |
| Total Assets | 2,039 | 1,799 | 2,043 | 1,884 | 2,231 | 2,097 | 2,325 | 2,529 | 2,590 | 2,739 | 2,903 | 2,902 | 3,640 |
Below is a detailed analysis of the balance sheet data for Akzo Nobel India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 46.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 46.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,208.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,283.00 Cr. (Mar 2025) to 2,208.00 Cr., marking an increase of 925.00 Cr..
- For Borrowings, as of Sep 2025, the value is 71.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 62.00 Cr. (Mar 2025) to 71.00 Cr., marking an increase of 9.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,315.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,511.00 Cr. (Mar 2025) to 1,315.00 Cr., marking a decrease of 196.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,640.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,902.00 Cr. (Mar 2025) to 3,640.00 Cr., marking an increase of 738.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,580.00 Cr.. The value appears strong and on an upward trend. It has increased from 481.00 Cr. (Mar 2025) to 1,580.00 Cr., marking an increase of 1,099.00 Cr..
- For CWIP, as of Sep 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2025) to 74.00 Cr., marking an increase of 7.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,987.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,354.00 Cr. (Mar 2025) to 1,987.00 Cr., marking a decrease of 367.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,640.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,902.00 Cr. (Mar 2025) to 3,640.00 Cr., marking an increase of 738.00 Cr..
Notably, the Reserves (2,208.00 Cr.) exceed the Borrowings (71.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 192.00 | 261.00 | 257.00 | 326.00 | 297.00 | 339.00 | 306.00 | 279.00 | 364.00 | 456.00 | 573.00 | 580.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 48 | 42 | 49 | 58 | 53 | 56 | 54 | 62 | 57 | 53 | 53 | 52 |
| Inventory Days | 86 | 95 | 89 | 107 | 84 | 85 | 107 | 135 | 129 | 95 | 100 | 95 |
| Days Payable | 130 | 119 | 145 | 164 | 159 | 131 | 171 | 220 | 164 | 138 | 164 | 151 |
| Cash Conversion Cycle | 4 | 17 | -7 | 1 | -22 | 9 | -10 | -23 | 22 | 11 | -10 | -3 |
| Working Capital Days | -62 | -12 | -59 | 15 | 10 | 20 | -3 | -14 | 14 | 4 | -2 | 22 |
| ROCE % | 16% | 25% | 26% | 27% | 40% | 24% | 27% | 22% | 28% | 35% | 42% | 42% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Multi Cap Fund | 960,885 | 0.64 | 318.13 | 814,894 | 2025-12-15 00:06:32 | 17.92% |
| HDFC Small Cap Fund | 847,275 | 0.74 | 280.52 | 445,231 | 2025-12-15 00:06:32 | 90.3% |
| ICICI Prudential Value Fund | 706,501 | 0.39 | 233.91 | N/A | N/A | N/A |
| Aditya Birla Sun Life Large Cap Fund | 520,550 | 0.55 | 172.34 | 706,250 | 2025-12-15 00:06:32 | -26.29% |
| HDFC Childrens Fund | 463,675 | 1.44 | 153.51 | N/A | N/A | N/A |
| HDFC Multi Cap Fund | 400,471 | 0.67 | 132.59 | 325,471 | 2025-12-15 00:06:32 | 23.04% |
| Tata Small Cap Fund | 287,484 | 0.83 | 95.18 | N/A | N/A | N/A |
| ICICI Prudential Equity Savings Fund | 228,483 | 0.43 | 75.65 | N/A | N/A | N/A |
| Tata Large & Mid Cap Fund | 181,800 | 0.69 | 60.19 | N/A | N/A | N/A |
| HDFC Hybrid Equity Fund | 177,752 | 0.24 | 58.85 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 94.31 | 93.68 | 73.58 | 63.70 | 45.60 |
| Diluted EPS (Rs.) | 94.31 | 93.68 | 73.58 | 63.70 | 45.60 |
| Cash EPS (Rs.) | 114.04 | 111.85 | 91.78 | 80.44 | 62.22 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 292.09 | 292.02 | 289.03 | 276.55 | 282.88 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 292.35 | 292.29 | 289.30 | 276.81 | 283.14 |
| Revenue From Operations / Share (Rs.) | 899.16 | 870.68 | 835.63 | 692.00 | 532.17 |
| PBDIT / Share (Rs.) | 147.05 | 146.77 | 121.43 | 100.04 | 80.00 |
| PBIT / Share (Rs.) | 127.41 | 128.68 | 103.30 | 83.36 | 63.41 |
| PBT / Share (Rs.) | 125.25 | 125.93 | 100.20 | 80.61 | 61.14 |
| Net Profit / Share (Rs.) | 94.39 | 93.76 | 73.65 | 63.76 | 45.63 |
| NP After MI And SOA / Share (Rs.) | 94.39 | 93.76 | 73.65 | 63.76 | 45.63 |
| PBDIT Margin (%) | 16.35 | 16.85 | 14.53 | 14.45 | 15.03 |
| PBIT Margin (%) | 14.16 | 14.77 | 12.36 | 12.04 | 11.91 |
| PBT Margin (%) | 13.92 | 14.46 | 11.99 | 11.64 | 11.48 |
| Net Profit Margin (%) | 10.49 | 10.76 | 8.81 | 9.21 | 8.57 |
| NP After MI And SOA Margin (%) | 10.49 | 10.76 | 8.81 | 9.21 | 8.57 |
| Return on Networth / Equity (%) | 32.31 | 32.10 | 25.48 | 23.05 | 16.12 |
| Return on Capital Employeed (%) | 39.88 | 39.55 | 31.82 | 26.94 | 20.05 |
| Return On Assets (%) | 14.79 | 14.69 | 12.22 | 11.19 | 8.20 |
| Asset Turnover Ratio (%) | 1.41 | 1.40 | 1.43 | 1.23 | 0.99 |
| Current Ratio (X) | 1.38 | 1.35 | 1.48 | 1.49 | 1.60 |
| Quick Ratio (X) | 0.96 | 0.92 | 1.00 | 0.92 | 1.15 |
| Inventory Turnover Ratio (X) | 6.73 | 3.32 | 3.30 | 3.08 | 2.56 |
| Dividend Payout Ratio (NP) (%) | 100.72 | 96.08 | 81.52 | 109.89 | 74.56 |
| Dividend Payout Ratio (CP) (%) | 83.36 | 80.54 | 65.42 | 87.10 | 54.68 |
| Earning Retention Ratio (%) | -0.72 | 3.92 | 18.48 | -9.89 | 25.44 |
| Cash Earning Retention Ratio (%) | 16.64 | 19.46 | 34.58 | 12.90 | 45.32 |
| Interest Coverage Ratio (X) | 68.28 | 53.42 | 39.18 | 31.39 | 35.34 |
| Interest Coverage Ratio (Post Tax) (X) | 44.83 | 35.13 | 24.77 | 20.87 | 21.16 |
| Enterprise Value (Cr.) | 16078.36 | 10323.76 | 9851.79 | 8249.97 | 9768.88 |
| EV / Net Operating Revenue (X) | 3.93 | 2.61 | 2.59 | 2.62 | 4.03 |
| EV / EBITDA (X) | 24.03 | 15.46 | 17.83 | 18.12 | 26.84 |
| MarketCap / Net Operating Revenue (X) | 4.00 | 2.74 | 2.74 | 2.77 | 4.34 |
| Retention Ratios (%) | -0.72 | 3.91 | 18.47 | -9.89 | 25.43 |
| Price / BV (X) | 12.32 | 8.16 | 7.92 | 6.92 | 8.16 |
| Price / Net Operating Revenue (X) | 4.00 | 2.74 | 2.74 | 2.77 | 4.34 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 |
After reviewing the key financial ratios for Akzo Nobel India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 94.31. This value is within the healthy range. It has increased from 93.68 (Mar 24) to 94.31, marking an increase of 0.63.
- For Diluted EPS (Rs.), as of Mar 25, the value is 94.31. This value is within the healthy range. It has increased from 93.68 (Mar 24) to 94.31, marking an increase of 0.63.
- For Cash EPS (Rs.), as of Mar 25, the value is 114.04. This value is within the healthy range. It has increased from 111.85 (Mar 24) to 114.04, marking an increase of 2.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 292.09. It has increased from 292.02 (Mar 24) to 292.09, marking an increase of 0.07.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 292.35. It has increased from 292.29 (Mar 24) to 292.35, marking an increase of 0.06.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 899.16. It has increased from 870.68 (Mar 24) to 899.16, marking an increase of 28.48.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 147.05. This value is within the healthy range. It has increased from 146.77 (Mar 24) to 147.05, marking an increase of 0.28.
- For PBIT / Share (Rs.), as of Mar 25, the value is 127.41. This value is within the healthy range. It has decreased from 128.68 (Mar 24) to 127.41, marking a decrease of 1.27.
- For PBT / Share (Rs.), as of Mar 25, the value is 125.25. This value is within the healthy range. It has decreased from 125.93 (Mar 24) to 125.25, marking a decrease of 0.68.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 94.39. This value is within the healthy range. It has increased from 93.76 (Mar 24) to 94.39, marking an increase of 0.63.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 94.39. This value is within the healthy range. It has increased from 93.76 (Mar 24) to 94.39, marking an increase of 0.63.
- For PBDIT Margin (%), as of Mar 25, the value is 16.35. This value is within the healthy range. It has decreased from 16.85 (Mar 24) to 16.35, marking a decrease of 0.50.
- For PBIT Margin (%), as of Mar 25, the value is 14.16. This value is within the healthy range. It has decreased from 14.77 (Mar 24) to 14.16, marking a decrease of 0.61.
- For PBT Margin (%), as of Mar 25, the value is 13.92. This value is within the healthy range. It has decreased from 14.46 (Mar 24) to 13.92, marking a decrease of 0.54.
- For Net Profit Margin (%), as of Mar 25, the value is 10.49. This value exceeds the healthy maximum of 10. It has decreased from 10.76 (Mar 24) to 10.49, marking a decrease of 0.27.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.49. This value is within the healthy range. It has decreased from 10.76 (Mar 24) to 10.49, marking a decrease of 0.27.
- For Return on Networth / Equity (%), as of Mar 25, the value is 32.31. This value is within the healthy range. It has increased from 32.10 (Mar 24) to 32.31, marking an increase of 0.21.
- For Return on Capital Employeed (%), as of Mar 25, the value is 39.88. This value is within the healthy range. It has increased from 39.55 (Mar 24) to 39.88, marking an increase of 0.33.
- For Return On Assets (%), as of Mar 25, the value is 14.79. This value is within the healthy range. It has increased from 14.69 (Mar 24) to 14.79, marking an increase of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.41. It has increased from 1.40 (Mar 24) to 1.41, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 1.5. It has increased from 1.35 (Mar 24) to 1.38, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1. It has increased from 0.92 (Mar 24) to 0.96, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.73. This value is within the healthy range. It has increased from 3.32 (Mar 24) to 6.73, marking an increase of 3.41.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 100.72. This value exceeds the healthy maximum of 50. It has increased from 96.08 (Mar 24) to 100.72, marking an increase of 4.64.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 83.36. This value exceeds the healthy maximum of 50. It has increased from 80.54 (Mar 24) to 83.36, marking an increase of 2.82.
- For Earning Retention Ratio (%), as of Mar 25, the value is -0.72. This value is below the healthy minimum of 40. It has decreased from 3.92 (Mar 24) to -0.72, marking a decrease of 4.64.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 16.64. This value is below the healthy minimum of 40. It has decreased from 19.46 (Mar 24) to 16.64, marking a decrease of 2.82.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 68.28. This value is within the healthy range. It has increased from 53.42 (Mar 24) to 68.28, marking an increase of 14.86.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 44.83. This value is within the healthy range. It has increased from 35.13 (Mar 24) to 44.83, marking an increase of 9.70.
- For Enterprise Value (Cr.), as of Mar 25, the value is 16,078.36. It has increased from 10,323.76 (Mar 24) to 16,078.36, marking an increase of 5,754.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.93. This value exceeds the healthy maximum of 3. It has increased from 2.61 (Mar 24) to 3.93, marking an increase of 1.32.
- For EV / EBITDA (X), as of Mar 25, the value is 24.03. This value exceeds the healthy maximum of 15. It has increased from 15.46 (Mar 24) to 24.03, marking an increase of 8.57.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. It has increased from 2.74 (Mar 24) to 4.00, marking an increase of 1.26.
- For Retention Ratios (%), as of Mar 25, the value is -0.72. This value is below the healthy minimum of 30. It has decreased from 3.91 (Mar 24) to -0.72, marking a decrease of 4.63.
- For Price / BV (X), as of Mar 25, the value is 12.32. This value exceeds the healthy maximum of 3. It has increased from 8.16 (Mar 24) to 12.32, marking an increase of 4.16.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. It has increased from 2.74 (Mar 24) to 4.00, marking an increase of 1.26.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Akzo Nobel India Ltd:
- Net Profit Margin: 10.49%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 39.88% (Industry Average ROCE: 23.02%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 32.31% (Industry Average ROE: 20.17%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 44.83
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.96
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 37.5 (Industry average Stock P/E: 47.66)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.49%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Paints/Varnishes | 801A, South City Business Park, 770, Anandapur, Kolkata West Bengal 700107 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajiv Rajgopal | Chairman & Managing Director |
| Mr. Krishna Rallapalli | WholeTime Director & CFO |
| Mr. Rohit G Totla | Whole Time Director |
| Mr. Hemant Sahai | Independent Director |
| Mr. Anil Chaudhry | Independent Director |
| Ms. Namrata Kaul | Independent Director |
FAQ
What is the intrinsic value of Akzo Nobel India Ltd?
Akzo Nobel India Ltd's intrinsic value (as of 04 January 2026) is ₹4930.41 which is 53.50% higher the current market price of ₹3,212.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹14,626 Cr. market cap, FY2025-2026 high/low of ₹3,958/3,022, reserves of ₹2,208 Cr, and liabilities of ₹3,640 Cr.
What is the Market Cap of Akzo Nobel India Ltd?
The Market Cap of Akzo Nobel India Ltd is 14,626 Cr..
What is the current Stock Price of Akzo Nobel India Ltd as on 04 January 2026?
The current stock price of Akzo Nobel India Ltd as on 04 January 2026 is ₹3,212.
What is the High / Low of Akzo Nobel India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Akzo Nobel India Ltd stocks is ₹3,958/3,022.
What is the Stock P/E of Akzo Nobel India Ltd?
The Stock P/E of Akzo Nobel India Ltd is 37.5.
What is the Book Value of Akzo Nobel India Ltd?
The Book Value of Akzo Nobel India Ltd is 495.
What is the Dividend Yield of Akzo Nobel India Ltd?
The Dividend Yield of Akzo Nobel India Ltd is 3.11 %.
What is the ROCE of Akzo Nobel India Ltd?
The ROCE of Akzo Nobel India Ltd is 41.7 %.
What is the ROE of Akzo Nobel India Ltd?
The ROE of Akzo Nobel India Ltd is 32.2 %.
What is the Face Value of Akzo Nobel India Ltd?
The Face Value of Akzo Nobel India Ltd is 10.0.